×

Once registered, you can:

  • - Read additional free articles each month
  • - Comment on articles and featured creative work
  • - Get our curated newsletters delivered to your inbox

By registering you agree to our privacy policy, terms & conditions and to receive occasional emails from Ad Age. You may unsubscribe at any time.

Are you a print subscriber? Activate your account.

Pfizer's Twitter Dilemma

PR Chief Bemoans Lack of Federal Guidelines

By Published on .

NEW YORK (AdAge.com) -- Many marketers are struggling with the new world of Twitter and social media but few face the dilemma of pharmaceutical giants such as Pfizer. Twitter-using consumers are highly interested in their drug products, but their marketing communications are rigidly constrained by federal regulations. While Pfizer has just launched a Twitter site, the company is not exactly sure what it's allowed to say on it.

Advertising Age Embedded Player
In this article:
Most Popular